Catalyst Wire Dossier Catalyst Wire Dossier

Trans-resveratrol

trans-resveratrol · OMNIFARMA LLC
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Trans-resveratrol, covering 2013-02-18 to 2025-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Trans-resveratrol's Influence on the Development of CHF in Early Postmenopausal Women with HTN and Reduced BMD [NA]

See pricing